BRCA2 germline mutations in Swedish breast cancer families
被引:0
作者:
Jindong Chen
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Jindong Chen
Moraima Zelada Hedman
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Moraima Zelada Hedman
Brita Wasteson Arver
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Brita Wasteson Arver
Stefan Sigurdsson
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Stefan Sigurdsson
Jorunn Erla Eyfjörd
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Jorunn Erla Eyfjörd
Annika Lindblom
论文数: 0引用数: 0
h-index: 0
机构:Molecular Medicine,
Annika Lindblom
机构:
[1] Molecular Medicine,
[2] Karolinska Institute,undefined
[3] Molecular and Cell Biology Research Laboratory,undefined
[4] Icelandic Cancer Society,undefined
来源:
European Journal of Human Genetics
|
1998年
/
6卷
关键词:
hereditary breast cancer;
breast cancer susceptibility gene;
cancer family;
gene mutation;
familial breast cancer;
mutations screening;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Mutations in the breast cancer susceptibility gene (BRCA2) are believed to be responsible for a significant fraction of hereditary breast cancer. To determine the BRCA2 mutation spectrum in a subset of Swedish breast cancer families, 162 families were screened for germline mutations in this gene. A combination of RT-PCR, PTT and direct DNA sequencing was used. Two mutations and one previously reported polymorphic variant resulting in a truncated protein were identified. Our data suggest that only a small proportion of Swedish breast cancer families is attributable to BRCA2 germline mutations. This result, in combination with the low frequency of BRCA1 germline mutations identified in our previous study, suggests additional high penetrant as well as low penetrant breast cancer susceptibility genes are involved in familial breast cancer.